Literature DB >> 16293895

Factors associated with failure of noninvasive positive pressure ventilation in the emergency department.

Paolo G Merlani1, Patrick Pasquina, Jean Max Granier, Miriam Treggiari, Olivier Rutschmann, Bara Ricou.   

Abstract

OBJECTIVES: To determine the factors associated with failure of noninvasive positive pressure ventilation (NPPV) in patients presenting with acute respiratory failure to the emergency department (ED).
METHODS: The authors retrospectively analyzed patients admitted to the ED for acute respiratory failure (defined as a PaCO2 level >45 mm Hg, and pH < or = 7.35 or a PaO2/FiO2 ratio < 250 mm Hg) and who were treated with NPPV. NPPV was delivered routinely according to an institutional protocol. Failure of NPPV was defined as the requirement of endotracheal intubation at any time.
RESULTS: A total of 104 patients were included. NPPV failed in 31% (32/104), and the mortality was significantly higher in this group (12/32 [44%]) compared with patients who were not intubated (2/72 [3%]) (p < 0.0001). Factors associated with failure of NPPV were Glasgow Coma Scale score < 13 at ED admission (odds ratio [OR], 3.67; 95% confidence interval [CI] = 1.33 to 10.07), pH < or = 7.35 (OR, 3.23; 95% CI = 1.25 to 8.31), and respiratory rate (RR) > or =20 min(-1) (OR, 3.86; 95% CI = 1.33 to 11.17) after one hour of NPPV. The negative predictive value for NPPV failure was 86% (95% CI = 70% to 95%) for RR > or =20 min(-1). In the multivariate analysis, pH < or = 7.35 and RR > or =20 min(-1) after one hour of NPPV were independently associated with NPPV failure (adjusted ORs, 3.51; 95% CI = 1.29 to 9.62 and 3.55; 95% CI = 1.13 to 11.20, respectively).
CONCLUSIONS: Patients with pH < or = 7.35 and an RR > or =20 min(-1) after one hour of NPPV had an increased risk of subsequent endotracheal intubation.

Entities:  

Mesh:

Year:  2005        PMID: 16293895     DOI: 10.1197/j.aem.2005.07.018

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   3.451


  6 in total

1.  Role of sedation for agitated patients undergoing noninvasive ventilation: clinical practice in a tertiary referral hospital.

Authors:  Takeshi Matsumoto; Keisuke Tomii; Ryo Tachikawa; Kojiro Otsuka; Kazuma Nagata; Kyoko Otsuka; Atsushi Nakagawa; Michiaki Mishima; Kazuo Chin
Journal:  BMC Pulm Med       Date:  2015-07-13       Impact factor: 3.317

2.  Noninvasive ventilation-neurally adjusted ventilator assist for management of acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Vijay Hadda; Tajamul Hussain Shah; Karan Madan; Anant Mohan; Gopi C Khilnani; Randeep Guleria
Journal:  Lung India       Date:  2018 Jan-Feb

3.  Effectiveness assessment of a guideline based protocol for ventilatory support management of COPD exacerbations in an emergency department.

Authors:  Franciele Plachi; Fernando Nataniel Vieira; Danilo Cortozi Berton; Marli Knorst; Alexandre Simões Dias; Fernanda Machado Balzan
Journal:  Braz J Phys Ther       Date:  2017-07-05       Impact factor: 3.377

4.  Feasibility of Early Noninvasive Ventilation Strategy for Patients with Acute Onset Shortness of Breath in Emergency Department - A Prospective Interventional Study.

Authors:  Mohammed Ismail Nizami; Ashima Sharma; Kavitha Jayaram
Journal:  Indian J Crit Care Med       Date:  2019-09

5.  Can patients with moderate to severe acute respiratory failure from COPD be treated safely with noninvasive mechanical ventilation on the ward?

Authors:  Murat Yalcinsoy; Cuneyt Salturk; Selahattin Oztas; Sinem Gungor; Ipek Ozmen; Feyyaz Kabadayi; Aysem Askim Oztim; Emine Aksoy; Nalan Adıguzel; Ozlem Oruc; Zuhal Karakurt
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-05-31

6.  Combined noninvasive ventilation and mechanical insufflator-exsufflator for acute respiratory failure in patients with neuromuscular disease: effectiveness and outcome predictors.

Authors:  Tai-Heng Chen; Wen-Chen Liang; I-Chen Chen; Yi-Ching Liu; Jong-Hau Hsu; Yuh-Jyh Jong
Journal:  Ther Adv Respir Dis       Date:  2019 Jan-Dec       Impact factor: 4.031

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.